Strata Oncology logo

Strata Oncology

31 employees · est. 2016 · Ann Arbor, United States

VS
Tempus AI logo

Tempus AI

Tempus AI, Inc. (NASDAQ: TEM) is a technology company leading the adoption of AI to advance precision medicine.

3124 employees · est. 2015 · Chicago, United States

Tempus AI is the older company (2016 vs 2015); Tempus AI is the larger of the two.

Side-by-Side Comparison

Strata Oncology Tempus AI
Founded
2016 2015 older
Headquarters
Ann Arbor, United States Chicago, United States
Employees
31 3124 larger
Industry
Biotechnology, Health Care, Medical Devices AI, Biotechnology, Health Care
Funding Stage
Series C Post Ipo Debt
Total Funding
$128.00M $1.64B
Funding Rounds
3 15
Services
Not tracked yet AI-Enabled Healthcare Solutions, Diagnostic Tools Development, Healthcare Data Analytics, Research Program Partnerships
Target Customers
Not tracked yet Healthcare Providers, Research Institutions, Medical Professionals, Healthcare Researchers
Taxonomy
Precision Oncology, Cancer Care, Molecular Profiling, Genomic Sequencing, Clinical Trials, Personalized Medicine, Biopsies, High-throughput CLIA Lab, Drug Trials, Healthcare Systems, Precision Medicine, Next-generation Sequencing, Bioinformatics, Health Technology Precision Medicine, Multimodal Data, Clinical Data Interpretation, Molecular Data Analysis, Personalized Patient Care, Therapeutics Development, AI-Enabled Healthcare Solutions, Patient Data Utilization, Healthcare Operating Systems, Medical Data Libraries, Healthcare Innovation
Website
strataoncology.com tempus.com
Strata Oncology logo

About Strata Oncology

Strata Oncology is a high-growth, state-of-the-art, precision oncology company, founded in 2016 and headquartered in the United States. The company's mission is to deliver a new standard of care in cancer treatment by integrating molecular profiling, decision support, and clinical trial participatio...

Tempus AI logo

About Tempus AI

Tempus AI, Inc. (NASDAQ: TEM) is at the forefront of integrating artificial intelligence into the healthcare sector, emphasizing the power of precision medicine. Since its founding in 2015, Tempus has focused on building one of the largest libraries of multimodal medical data globally, ensuring that...

We will tell you when either one moves

BounceWatch watches Strata Oncology and Tempus AI for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Strata Oncology and Tempus AI — by email.

Frequently Asked Questions

Strata Oncology. Tempus AI — Tempus AI, Inc. (NASDAQ: TEM) is a technology company leading the adoption of AI to advance precision medicine. . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Strata Oncology has raised $128.00M while Tempus AI has raised $1.64B.
Strata Oncology and Tempus AI operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Strata Oncology with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Strata Oncology on 11 Sep 2024, and Tempus AI on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy